Literature DB >> 22398578

Diffusion of protein through the human cornea.

Resmi A Charalel1, Kristin Engberg, Jaan Noolandi, Jennifer R Cochran, Curtis Frank, Christopher N Ta.   

Abstract

AIMS: To determine the rate of diffusion of myoglobin and bovine serum albumin (BSA) through the human cornea. These small proteins have hydrodynamic diameters of approximately 4.4 and 7.2 nm, and molecular weights of 16.7 and 66 kDa, for myoglobin and BSA, respectively.
METHODS: Diffusion coefficients were measured using a diffusion chamber where the protein of interest and balanced salt solution were in different chambers separated by an ex vivo human cornea. Protein concentrations in the balanced salt solution chamber were measured over time. Diffusion coefficients were calculated using equations derived from Fick's law and conservation of mass in a closed system.
RESULTS: Our experiments demonstrate that the diffusion coefficient of myoglobin is 5.5 ± 0.9 × 10(-8) cm(2)/s (n = 8; SD = 1.3 × 10(-8) cm(2)/s; 95% CI: 4.6 × 10(-8) to 6.4 × 10(-8) cm(2)/s) and the diffusion coefficient of BSA is 3.1 ± 1.0 × 10(-8) cm(2)/s (n = 8; SD = 1.4 × 10(-8) cm(2)/s; 95% CI: 2.1 × 10(-8) to 4.1 × 10(-8) cm(2)/s).
CONCLUSIONS: Our study suggests that molecules as large as 7.2 nm may be able to passively diffuse through the human cornea. With applications in pharmacotherapy and the development of an artificial cornea, further experiments are warranted to fully understand the limits of human corneal diffusion and its clinical relevance.
Copyright © 2012 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22398578      PMCID: PMC3569487          DOI: 10.1159/000329794

Source DB:  PubMed          Journal:  Ophthalmic Res        ISSN: 0030-3747            Impact factor:   2.892


  10 in total

1.  Physicochemical determinants of drug diffusion across the conjunctiva, sclera, and cornea.

Authors:  I Ahmed; R D Gokhale; M V Shah; T F Patton
Journal:  J Pharm Sci       Date:  1987-08       Impact factor: 3.534

2.  Determination of human lens capsule permeability and its feasibility as a replacement for Bruch's membrane.

Authors:  Christina J Lee; Jonathan A Vroom; Harvey A Fishman; Stacey F Bent
Journal:  Biomaterials       Date:  2005-09-30       Impact factor: 12.479

3.  Intraocular concentrations of gatifloxacin and moxifloxacin in the anterior chamber via diffusion through the cornea using collagen shields.

Authors:  Guy Kleinmann; Scott Larson; Irmingard M Neuhann; Anne C Hunold; Russell LeBoyer; Scott Hickman; Nick Mamalis; Randall J Olson
Journal:  Cornea       Date:  2006-02       Impact factor: 2.651

4.  Mechanisms of corneal drug penetration. I: In vivo and in vitro kinetics.

Authors:  G M Grass; J R Robinson
Journal:  J Pharm Sci       Date:  1988-01       Impact factor: 3.534

5.  The dynamics of IgG in the cornea.

Authors:  M Allansmith; A de Ramus; D Maurice
Journal:  Invest Ophthalmol Vis Sci       Date:  1979-09       Impact factor: 4.799

6.  Glucose permeability of human, bovine, and porcine corneas in vitro.

Authors:  David Myung; Kristen Derr; Philip Huie; Jaan Noolandi; Kathryn P Ta; Christopher N Ta
Journal:  Ophthalmic Res       Date:  2006-01-06       Impact factor: 2.892

7.  A dataset of human cornea proteins identified by Peptide mass fingerprinting and tandem mass spectrometry.

Authors:  Henrik Karring; Ida B Thøgersen; Gordon K Klintworth; Torben Møller-Pedersen; Jan J Enghild
Journal:  Mol Cell Proteomics       Date:  2005-05-23       Impact factor: 5.911

8.  The rate of diffusion of fluorophores through the corneal epithelium and stroma.

Authors:  M Araie; D Maurice
Journal:  Exp Eye Res       Date:  1987-01       Impact factor: 3.467

9.  Efficient intraocular penetration of topical anti-TNF-alpha single-chain antibody (ESBA105) to anterior and posterior segment without penetration enhancer.

Authors:  Michael Ottiger; Michael A Thiel; Ulrich Feige; Peter Lichtlen; David M Urech
Journal:  Invest Ophthalmol Vis Sci       Date:  2008-08-29       Impact factor: 4.799

10.  Boston keratoprosthesis outcomes and complications.

Authors:  Hall F Chew; Brandon D Ayres; Kristin M Hammersmith; Christopher J Rapuano; Peter R Laibson; Jonathan S Myers; Ya-Ping Jin; Elisabeth J Cohen
Journal:  Cornea       Date:  2009-10       Impact factor: 2.651

  10 in total
  4 in total

Review 1.  Ocular delivery of proteins and peptides: Challenges and novel formulation approaches.

Authors:  Abhirup Mandal; Dhananjay Pal; Vibhuti Agrahari; Hoang My Trinh; Mary Joseph; Ashim K Mitra
Journal:  Adv Drug Deliv Rev       Date:  2018-01-13       Impact factor: 15.470

2.  Graphene-Lined Porous Gelatin Glycidyl Methacrylate Hydrogels: Implications for Tissue Engineering.

Authors:  Sina Sharifi; Hannah Sharifi; Ali Akbari; Claes H Dohlman; Eleftherios I Paschalis; Miguel Gonzalez-Andrades; Jing Kong; James Chodosh
Journal:  ACS Appl Nano Mater       Date:  2021-11-10

Review 3.  Ocular delivery of macromolecules.

Authors:  Yoo Chun Kim; Bryce Chiang; Xianggen Wu; Mark R Prausnitz
Journal:  J Control Release       Date:  2014-07-03       Impact factor: 9.776

4.  Therapeutic Ultrasound for Topical Corneal Delivery of Macromolecules.

Authors:  Hanaa H Almogbil; Felipe Montecinos-Franjola; Camille Daszynski; William J Conlon; Justin S Hachey; Giavanna Corazza; Erik A Rodriguez; Vesna Zderic
Journal:  Transl Vis Sci Technol       Date:  2022-08-01       Impact factor: 3.048

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.